What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Genetics
His primary areas of study are Receptor, Cell biology, Molecular biology, Lymphokine-activated killer cell and Natural killer cell.
His studies deal with areas such as Natural Cytotoxicity Triggering Receptor 1 and CD94/NKG2 as well as Receptor.
His research integrates issues of Interleukin 12 and Cytotoxicity in his study of Cell biology.
He combines subjects such as Complementary DNA, Antibody, Signal transduction and Phosphorylation with his study of Molecular biology.
His Lymphokine-activated killer cell research includes elements of NK-92 and Natural killer T cell.
His study in Natural killer cell is interdisciplinary in nature, drawing from both Human leukocyte antigen, Histocompatibility Antigens Class I, Cytolysis, Bone marrow transplantation and Major histocompatibility complex.
His most cited work include:
- Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis (1532 citations)
- RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS (768 citations)
- Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells (687 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Receptor, Molecular biology, Immunology, Cell biology and Human leukocyte antigen.
His Receptor research is multidisciplinary, incorporating elements of Natural killer cell, Cytolysis, Cytotoxicity and Major histocompatibility complex.
His research in Molecular biology intersects with topics in Cell culture, CD3, CD8, Immunoglobulin superfamily and Complementary DNA.
His study on Immunology is mostly dedicated to connecting different topics, such as NKG2D.
His study in Cell biology is interdisciplinary in nature, drawing from both Interleukin 12, Natural Cytotoxicity Triggering Receptor 1, Lymphokine-activated killer cell and MHC class I.
His work investigates the relationship between Human leukocyte antigen and topics such as Virology that intersect with problems in Antibody.
He most often published in these fields:
- Receptor (44.15%)
- Molecular biology (32.98%)
- Immunology (29.79%)
What were the highlights of his more recent work (between 2008-2021)?
- Immunology (29.79%)
- Receptor (44.15%)
- Virology (9.57%)
In recent papers he was focusing on the following fields of study:
His main research concerns Immunology, Receptor, Virology, Human leukocyte antigen and Cell biology.
The various areas that Roberto Biassoni examines in his Immunology study include Nephrotic syndrome and Calcineurin.
His research integrates issues of Gene expression, Macaque, Natural killer T cell, CD8 and NKG2D in his study of Receptor.
His HLA-B study in the realm of Human leukocyte antigen interacts with subjects such as Subtyping.
His Cell biology research integrates issues from Cytotoxic T cell, Cytolysis, Innate immune system and Major histocompatibility complex.
Roberto Biassoni focuses mostly in the field of Genetics, narrowing it down to matters related to Molecular biology and, in some cases, Cell membrane.
Between 2008 and 2021, his most popular works were:
- NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo (258 citations)
- Human Natural Killer Receptors, Co‐Receptors, and Their Ligands (57 citations)
- Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation (51 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Genetics
His primary scientific interests are in Receptor, Immunology, Cell biology, CD8 and Interleukin 21.
His work on Cell activation as part of general Receptor study is frequently connected to Homo sapiens, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His work on Humanized antibody, Ofatumumab and Rituximab as part of his general Immunology study is frequently connected to Lung injury, thereby bridging the divide between different branches of science.
Roberto Biassoni combines subjects such as Cell type, Major histocompatibility complex, Cytolysis and Ligand with his study of Cell biology.
His CD8 study combines topics in areas such as Cell, In vitro and Cytokine.
Roberto Biassoni usually deals with Interleukin 21 and limits it to topics linked to NKG2D and Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
